Gritstone bio (NASDAQ:GRTS) Inc President & CEO Dr. Andrew Allen joined Proactive to discuss the Emeryville, California-based biotechnology group's latest clinical progress and upcoming milestones. Gritstone is advancing a portfolio of product candidates to treat and prevent viral diseases and solid tumors in pursuit of improving patient outcomes and eliminating disease.
Gritstone bio shares latest clinical progress in both oncology and infectious disease
